636 related articles for article (PubMed ID: 26235479)
21. Clinical characteristics influencing age at onset in psychotic disorders.
Ongür D; Lin L; Cohen BM
Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
[TBL] [Abstract][Full Text] [Related]
22. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
[TBL] [Abstract][Full Text] [Related]
23. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
[TBL] [Abstract][Full Text] [Related]
24. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
[TBL] [Abstract][Full Text] [Related]
25. Cannabis use and age at onset of schizophrenia.
Veen ND; Selten JP; van der Tweel I; Feller WG; Hoek HW; Kahn RS
Am J Psychiatry; 2004 Mar; 161(3):501-6. PubMed ID: 14992976
[TBL] [Abstract][Full Text] [Related]
26. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
[TBL] [Abstract][Full Text] [Related]
27. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
29. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
30. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
Manrique-Garcia E; Zammit S; Dalman C; Hemmingsson T; Andreasson S; Allebeck P
Psychol Med; 2012 Jun; 42(6):1321-8. PubMed ID: 21999906
[TBL] [Abstract][Full Text] [Related]
31. Reasons for cannabis use in men with and without psychosis.
Green B; Kavanagh DJ; Young RM
Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
[TBL] [Abstract][Full Text] [Related]
32. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in psychosis: normal or pathological?
Spauwen J; Krabbendam L; Lieb R; Wittchen HU; van Os J
Schizophr Res; 2003 Jul; 62(1-2):45-9. PubMed ID: 12765742
[TBL] [Abstract][Full Text] [Related]
34. Subjective effects of cannabis before the first psychotic episode.
Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
[TBL] [Abstract][Full Text] [Related]
35. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
van der Meer FJ; Velthorst E;
Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
[TBL] [Abstract][Full Text] [Related]
36. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
[TBL] [Abstract][Full Text] [Related]
37. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
[TBL] [Abstract][Full Text] [Related]
38. No additive effect of cannabis on cognition in schizophrenia.
Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
[TBL] [Abstract][Full Text] [Related]
39. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
40. [Motivational interviewing for cannabis users with psychotic disorders].
Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
